Article

Statin use may reduce risk of PCa recurrence

Statin drugs may lessen the risk for return of prostate cancer in individuals who have undergone radical prostatectomy.

Related Videos
Karyn S. Eilber, MD, answers a question during a Zoom video interview
Woman at doctor | Image Credit: © rocketclips - stock.adobe.com
1 expert in this video
Perry Xu, MD, answers a question during Zoom video interview
Suzanne B. Merrill, MD, FACS, answers a question during a Zoom video interview
Related Content
Doctor giving a consultation to a patient and explaining medical informations and diagnosis | © Pcess609 - stock.adobe.com
April 22nd 2025

Upper tract urothelial carcinoma: Key considerations and patient cases

Urology Times staff
A pair of roundtable discussions encompassed a range of topics related to UTUC, including clinical guidelines, treatment considerations, and patient cases.
Introducing Pearls & Perspectives, with Amy Pearlman, MD!
April 21st 2025

Introducing Pearls & Perspectives, with Amy Pearlman, MD!

Amy M. Pearlman, MD
Pearls & Perspectives, hosted by Amy Pearlman, MD, is the latest multimedia program from Urology Times.
Biomarkers in urology: Policy and legislative advances
April 22nd 2025

Biomarkers in urology: Policy and legislative advances

Ron Lanton, Esq
"The AACU has been discussing the evolution of state policy to ensure that biomarker testing, including PSA screening, is covered by payers," writes Ron Lanton, Esq.
Episode 4 Video: Moving Toward a Patient-Centered Approach in NMIBC Management
March 3rd 2025

Episode 4 Video: Moving Toward a Patient-Centered Approach in NMIBC Management

Max Kates, MD Neal Shore, MD, FACS Katie S. Murray, DO, MS
Panelists discuss the impact of long-term care in patients with non–muscle-invasive bladder cancer (NMIBC), considering the unique needs of specific patient groups and highlighting advancements in NMIBC treatment that may support better care experiences for patients.
Welcome to Fabulous Las Vegas Neon Sign | Image Credit: © somchaij - stock.adobe.com
April 21st 2025

AUA 2025: What to watch for in urologic oncology

Benjamin P. Saylor Hannah Clarke
We preview several noteworthy P2 presentations in the urologic oncology space.
blur image background of corridor in hospital or clinic image | Image Credit: @ whyframeshot - stock.adobe.com
April 18th 2025

U.S. News & World Report Names Michigan Institute of Urology’s Town Center ASC Among 2025 Best Ambulatory Surgery Centers

Michigan Institute of Urology
Ambulatory surgery centers were evaluated based entirely on objective, risk-adjusted measures of their patients’ outcomes.
© 2025 MJH Life Sciences

All rights reserved.